This inventor holds 1 USPTO granted patent. Top assignee: Resolution Pharmaceutical Inc.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of Robert Dufault
Introduction
Robert Dufault is an accomplished inventor based in Bramalea, Canada. He is known for his significant contributions to the field of radionuclide chelating compounds. His work has implications for both diagnosis and therapy in medical applications.
Latest Patents
Dufault holds a patent for "Hydrazino-type N.sub.2 S.sub.2 chelators." This invention provides radionuclide chelating compounds that can be conjugated to targeting molecules such as proteins, peptides, or antibodies. The resulting labeled targeting molecules may be utilized in various diagnostic and therapeutic procedures. He has 1 patent to his name.
Career Highlights
Robert Dufault has made notable strides in his career, particularly through his work at Resolution Pharmaceutical Inc. His innovative approach to chelation chemistry has positioned him as a key figure in the development of targeted therapies.
Collaborations
Dufault has collaborated with esteemed colleagues, including Alfred Pollack and Robert A. Kirby. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field.
Conclusion
Robert Dufault's contributions to the field of radionuclide chelation represent a significant advancement in medical technology. His innovative work continues to influence the landscape of diagnostic and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile